Brain biochemical correlates of the plasma homocysteine level: A proton magnetic resonance spectroscopy study in the elderly subjects

American Journal of Geriatric Psychiatry

Volumn 19, Issue 7, 2011, Pages 618-626

  Chen, Cheng Sheng ^a,c   Kuo, Yu Ting ^a,b   Tsai, Hui Yi ^e   Li, Chun Wei ^d   Lee, Chen Chang ^f   Yen, Cheng Fang ^a,c   Lin, Hsiu Fen ^a   Ko, Chih Hung ^a   Juo, Suh Hang Hank ^a,b,d   Yeh, Yi Chun ^a   Liu, Gin Chung ^b  

^a Department of Psychiatry ^*  (United Kingdom)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c Graduate Institute of Medicine   (United States)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^e St Joseph's Hospital   (Taiwan)

^f CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

female; homocysteine; late life; magnetic resonance spectroscopy; N acetylaspartate; sex

Indexed keywords

CHOLINE; CREATINE; HOMOCYSTEINE; INOSITOL; N ACETYLASPARTIC ACID;

AGED; AMINO ACID BLOOD LEVEL; ARTICLE; BASAL GANGLION; BRAIN LEVEL; FEMALE; FRONTAL LOBE; GROUPS BY AGE; HIPPOCAMPUS; HOMOCYSTEINE BLOOD LEVEL; HUMAN; LEFT HEMISPHERE; MALE; NORMAL HUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; SEX DIFFERENCE;

EID: 79960262056     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1097/JGP.0b013e318209ddf1     Document Type: Article

References (44)

1. Seshadri S, Beiser A, Selhub J, et al: Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002; 346:476-483 (Pubitemid 34441738)
2. Bjelland I, Tell GS, Vollset SE, et al: Folate, vitamin B12, homocysteine, and the MTHFR 677C→T polymorphism in anxiety and depression: the Hordaland Homocysteine Study. Arch Gen Psychiatry 2003; 60:618-626 (Pubitemid 36682319)
3. Chen CS, Tsai JC, Tsang HY, et al: Homocysteine levels, MTHFR C677T genotype, and MRI hyperintensities in late-onset major depressive disorder. Am J Geriatr Psychiatry 2005; 13:869-875
4. Riggs KM, Spiro A, III, Tucker K, et al: Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging Study. Am J Clin Nutr 1996; 63:306-314 (Pubitemid 26074688)
5. Dufouil C, Alperovitch A, Ducros V, et al: Homocysteine, white matter hyperintensities, and cognition in healthy elderly people. Ann Neurol 2003; 53:214-221 (Pubitemid 36164003)
6. Duthie SJ, Whalley LJ, Collins AR, et al: Homocysteine, B vitamin status, and cognitive function in the elderly. Am J Clin Nutr 2002; 75:908-913 (Pubitemid 34441260)
7. Morris MS, Jacques PF, Rosenberg IH, et al: Hyperhomocysteinemia associated with poor recall in the third National Health and Nutrition Examination Survey. Am J Clin Nutr 2001; 73:927-933 (Pubitemid 32405990)
8. Schafer JH, Glass TA, Bolla KI, et al: Homocysteine and cognitive function in a population-based study of older adults. J Am Geriatr Soc 2005; 53:381-388 (Pubitemid 41623514)
9. McCaddon A, Hudson P, Davies G, et al: Homocysteine and cognitive decline in healthy elderly. Dement Geriatr Cogn Disord 2001; 12:309-313 (Pubitemid 32656662)
10. Prins ND, Den Heijer T, Hofman A, et al: Homocysteine and cognitive function in the elderly: the Rotterdam Scan Study. Neurology 2002; 59:1375-1380 (Pubitemid 35285990)
11. Boxer AL, Kramer JH, Johnston K, et al: Executive dysfunction in hyperhomocystinemia responds to homocysteine-lowering treatment. Neurology 2005; 64:1431-1434 (Pubitemid 40570514)
12. Elias MF, Robbins MA, Budge MM, et al: Homocysteine, folate, and vitamins B6 and B12 blood levels in relation to cognitive performance: the Maine-Syracuse study. Psychosom Med 2006; 68:547-554 (Pubitemid 44297650)
13. Sachdev P: Homocysteine, cerebrovascular disease and brain atrophy. J Neurol Sci 2004; 226:25-29 (Pubitemid 39505400)
14. den Heijer T, Vermeer SE, Clarke R, et al: Homocysteine and brain atrophy on MRI of non-demented elderly. Brain 2003; 126: 170-175 (Pubitemid 36068567)
15. Naismith S, Hickie I,Ward PB, et al: Caudate nucleus volumes and genetic determinants of homocysteine metabolism in the prediction of psychomotor speed in older persons with depression. Am J Psychiatry 2002; 159:2096-2098 (Pubitemid 35423872)
16. Seshadri S, Wolf PA, Beiser AS, et al: Association of plasma total homocysteine levels with subclinical brain injury: cerebral volumes, white matter hyperintensity, and silent brain infarcts at volumetric magnetic resonance imaging in the Framingham Offspring Study. Arch Neurol 2008; 65:642-649 (Pubitemid 351679660)
17. Loscalzo J: Homocysteine and dementias. N Engl J Med 2002; 346:466-468
18. Bisschops RH, van der Graaf Y, Mali WP, et al: Elevated levels of plasma homocysteine are associated with neurotoxicity. Atherosclerosis 2004; 174:87-92 (Pubitemid 38595444)
19. Bates CJ, Mansoor MA, Gregory J, et al: Correlates of plasma homocysteine, cysteine and cysteinyl-glycine in respondents in the British National Diet and Nutrition Survey of young people aged 4-18 years, and a comparison with the survey of people aged 65 years and over. Br J Nutr 2002; 87:71-79 (Pubitemid 34116444)
20. Lussier-Cacan S, Xhignesse M, Piolot A, et al: Plasma total homocysteine in healthy subjects: sex-specific relation with biological traits. Am J Clin Nutr 1996; 64:587-593 (Pubitemid 26334238)
21. Morris MS, Jacques PF, Selhub J, et al: Total homocysteine and estrogen status indicators in the Third National Health and Nutrition Examination Survey. Am J Epidemiol 2000; 152:140-148 (Pubitemid 30463662)
22. Masse PG, Dosy J, Cole DE, et al: Elevation of plasma homocysteine in natural menopause can not be explained by a lack of vitamin coenzyme availability: relevance to the risk of cardiovascular disease. J Nutr Health Aging 2005; 9:59-64 (Pubitemid 40332875)
23. Murphy DG, DeCarli C, McIntosh AR, et al: Sex differences in human brain morphometry and metabolism: an in vivo quantitative magnetic resonance imaging and positron emission tomography study on the effect of aging. Arch Gen Psychiatry 1996; 53: 585-594 (Pubitemid 26240861)
24. Folstein MF, Folstein SE, McHugh PR: "Mini-mental state": A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198
25. HamiltonM: Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967; 6:278-296.
26. Wang TJ, Massaro JM, Levy D, et al: A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: The Framingham Heart Study. JAMA 2003; 290:1049-1056 (Pubitemid 37430445)
27. Bustillo JR, Lauriello J, Rowland LM, et al: Effects of chronic haloperidol and clozapine treatments on frontal and caudate neurochemistry in schizophrenia. Psychiatry Res 2001; 107:135-149 (Pubitemid 32868799)
28. Wilkinson ID, Paley MN, Miszkiel KA, et al: Cerebral volumes and spectroscopic proton metabolites on MR: is sex important? Magn Reson Imaging 1997; 15:243-248 (Pubitemid 27173237)
29. Sijens PE, Oudkerk M, de Leeuw FE, et al: 1H chemical shift imaging of the human brain at age 60-90 years reveals metabolic differences between women and men. Magn Reson Med 1999; 42:24-31 (Pubitemid 29325609)
30. Bramanti V, Bronzi D, Tomassoni D, et al: Effect of cholinecontaining phospholipids on transglutaminase activity in primary astroglial cell cultures. Clin Exp Hypertens 2008; 30:798-807
31. Chen CS, Chiang IC, Li CW, et al: Proton magnetic resonance spectroscopy of late-life major depressive disorder. Psychiatry Res 2009; 172:210-214
32. Yildiz-Yesiloglu A, Ankerst DP: Review of 1H magnetic resonance spectroscopy findings inmajor depressive disorder: A metaanalysis. Psychiatry Res 2006; 147:1-25 (Pubitemid 44067434)
33. Andres RH, Ducray AD, Schlattner U, et al: Functions and effects of creatine in the central nervous system. Brain Res Bull 2008; 76:329-343
34. Isaacks RE, Bender AS, Kim CY, et al: Effect of osmolality and anion channel inhibitors on myo-inositol efflux in cultured astrocytes. J Neurosci Res 1999; 57:866-871 (Pubitemid 29416117)
35. Halbreich U, Lumley LA, Palter S, et al: Possible acceleration of age effects on cognition following menopause. J Psychiatr Res 1995; 29:153-163
36. Maki PM: Estrogen effects on the hippocampus and frontal lobes. Int J Fertil Womens Med 2005; 50:67-71 (Pubitemid 46638715)
37. Braak H, Braak E: Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging 1997; 18:351-357 (Pubitemid 27435070)
38. Kim WK, Pae YS: Involvement of N-methyl-d-aspartate receptor and free radical in homocysteine-mediated toxicity on rat cerebellar granule cells in culture. Neurosci Lett 1996; 216: 117-120
39. Kruman, II, Culmsee C, Chan SL, et al: Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J Neurosci 2000; 20: 6920-6926
40. Irizarry MC, Gurol ME, Raju S, et al: Association of homocysteine with plasma amyloid beta protein in aging and neurodegenerative disease. Neurology 2005; 65:1402-1408 (Pubitemid 41552769)
41. Ho PI, Collins SC, Dhitavat S, et al: Homocysteine potentiates beta-amyloid neurotoxicity: role of oxidative stress. J Neurochem 2001; 78:249-253 (Pubitemid 32664406)
42. Kruman II, Kumaravel TS, Lohani A, et al: Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease. J Neurosci 2002; 22:1752-1762 (Pubitemid 35386293)
43. Obeid R, Herrmann W: Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia. FEBS Lett 2006; 580:2994-3005 (Pubitemid 43744523)
44. Zhang CE, Tian Q, Wei W, et al: Homocysteine induces tau phosphorylation by inactivating protein phosphatase 2A in rat hippocampus. Neurobiol Aging 2008; 29:1654-1665